Archive for September 2014

Andarix Pharmaceuticals Selected to Present at International Drug Conference in Copenhagen

ANDARIX Pharmaceuticals, a clinical stage company developing targeted peptide therapy for small cell lung and other cancers announced that its Chief Executive Officer, Chris Adams, will present at the Orphan Drugs Summit to be held in Copenhagen, Denmark from September 17-19, 2014. Conference agenda information are available at Mr. Adams will highlight recent results…

Read More